Crohn’s and Colitis Awareness Month puts the spotlight on mental wellbeing
Ahead of Crohn’s and Colitis Awareness Month in May, research released by Crohn’s & Colitis Australia reveals that 1 in 2 Australians living with Crohn’s disease and ulcerative colitis experience psychological distress associated with these chronic illnesses. Many people aren’t routinely assessed and lack access to services to support their physical and mental wellbeing.
New research gives voice to IBD patients, identifies major gaps in healthcare
Crohn’s & Colitis Australia (CCA) have released research findings from a national patient experience survey of IBD care. The 2018 Patience Experience Research Report demonstrates there is a high burden of Crohn’s disease and ulcerative colitis.
Important announcement from the Chair of Crohn's & Colitis Australia
It is with a mixture of sadness and gratitude that the Board of Directors announces Francesca Manglaviti’s departure as CEO of Crohn’s & Colitis Australia effective, 23 April 2018.
IBD Audit Now Underway
The Quality of Care Program has reached the implementation stage with the IBD Audit now underway, running from December 2015 to April 2016.
Interim Australian IBD Standards now available
Crohn’s & Colitis Australia (CCA) is pleased to release the Interim Australian IBD Standards: Standards of healthcare for people with inflammatory bowel disease in Australia.
New Tool to Improve Cancer Prevention in IBD
A new online tool that aims to radically improve cancer prevention in patients with inflammatory bowel disease (IBD) was launched on 30 June 2014 in Melbourne, Australia.
Australian study takes top award
A ground breaking Australian study, supported by Gandel Philanthropy through Crohn’s & Colitis Australia (CCA), took out top honours at the world’s premier inflammatory bowel disease congress, held in Copenhagen in February 2014.
$500,000 to improve IBD care
13 December, 2013
CCA is delighted to welcome an historic $500,000 matched funding agreement granted by the Federal Government that will change the lives of thousands of Australians living with incurable inflammatory bowel disease.